Toggle light / dark theme

New therapies for managing aging could emerge from research into a new gene, which scientists have identified as a key driver of degeneration.

Age-related diseases are strongly linked to inflammation which, when chronic, albeit low-grade, contributes to conditions such as cardiovascular disease, diabetes, neurodegeneration, and sarcopenia, significantly impacting health and longevity.

In a study published in Nature Communications, Dr. Ildus Akhmetov, a geneticist at Liverpool John Moores University’s School of Sport and Exercise Sciences, along with colleagues from Italy, Switzerland, and the Netherlands, uncovered groundbreaking insights into the role of the Ectodysplasin A2 Receptor (EDA2R) in this process.

The Earth’s magnetic field, a constant presence in our environment, has a subtle yet profound impact on human health. It operates at extremely low frequencies (around 7.83 Hz, known as the Schumann resonance) and low intensities (30−60 microTesla). Generated by electric currents in the conductive iron alloys in Earth’s core, this magnetic field protects us from a blast of solar particles (solar wind) that could literally obliterate life on Earth if allowed to enter our atmosphere (Figure 1). It also plays a crucial role in regulating our circadian rhythms and supporting overall cellular function. Our cells are used to living bathed in this interactive field of magnetism and electricity, and therapeutically, we can turn this into our advantage.

Figure 1. How Earth’s magnetic field interacts with the solar wind.

New therapies for managing ageing could emerge from research into a new gene, which scientists have identified as a key driver of degeneration.

Age-related diseases are strongly linked to inflammation which when chronic, albeit low-grade, contributes to conditions such as cardiovascular disease, diabetes, neurodegeneration, and sarcopenia, significantly impacting health and longevity.

In a study published in Nature Communications, Dr Ildus Akhmetov, a geneticist at Liverpool John Moores University’s School of Sport and Exercise Sciences, along with colleagues from Italy, Switzerland, and the Netherlands, uncovered groundbreaking insights into the role of the Ectodysplasin A2 Receptor (EDA2R) in this process.

Microbes, Ecology And Medicine — Dr. Sean M. Gibbons, Ph.D. — Associate Professor, Institute for Systems Biology (ISB)


Dr. Sean Gibbons, Ph.D. is Associate Professor at the Institute for Systems Biology (ISB — https://isbscience.org/people/sean-gibbons-phd/?tab=biography where his lab investigates how the structure and composition of evolving ecological networks of microorganisms change across environmental gradients, with a specific focus on how ecological communities in the gut change and adapt to individual people over their lifespans (i.e. host genotype, host development and host behavior) and how these changes impact human health (https://gibbons.isbscience.org/). His lab develops computational and experimental tools for investigating host-associated microbial communities to explore the interactions between ecology, evolution and ecosystem function, applying these insights to develop personalized interventions for improving human health and well-being.

Dr. Gibbons received his PhD in biophysical sciences from the University of Chicago in 2015, dual-advised by Jack Gilbert and Maureen Coleman. His graduate work focused on using microbial communities as empirical models for testing ecological theory.

Tech juggernaut Nvidia continued its winning streak on Wednesday, posting record quarterly revenue of $39.3 billion, up 12% from last quarter and 78% a year ago, compared to Wall Street’s projection of $38.3 billion. Sales for the year came in at $130.5 billion, up 114% from the previous year.

The company forecast revenue for next quarter to hit $43 billion, slightly above the Street’s projections. Gross margins dipped for a second consecutive quarter, however, coming in at 73.5%, matching the guidance CFO Colette Kress offered last quarter. She said margins are expected to temporarily drop into the low 70s amid the Blackwell rollout.

Another amazing quarter from the company, said Will Rhind, founder and CEO of GraniteShares, who manages leveraged ETFs that give investors double the exposure to long or short positions on the stock. The only slight thing that I guess you could probably nitpick on is margins.

Today, the company’s data center business accounts for most of its sales as customers, including nearly all of Big Tech, race to amass as much compute power as possible. The data center division’s $35.6 billion in revenue increased 93% from the same quarter last year and beat the Street’s expected number of $34.2 billion.